Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Debt (2020 - 2025)

Historic Total Debt for Burning Rock Biotech (BNR) over the last 3 years, with Q3 2025 value amounting to $253000.0.

  • Burning Rock Biotech's Total Debt changed N/A to $253000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $253000.0, marking a year-over-year change of. This contributed to the annual value of $372000.0 for FY2021, which is 9300.36% down from last year.
  • Latest data reveals that Burning Rock Biotech reported Total Debt of $253000.0 as of Q3 2025.
  • Over the past 5 years, Burning Rock Biotech's Total Debt peaked at $5.0 million during Q1 2021, and registered a low of $253000.0 during Q3 2025.